Anti-inflammatory Strategy in Acute Myocarditis — No Benefit
A short course of the interleukin-1 receptor antagonist, anakinra, appeared safe but did not reduce complications of acute myocarditis in the ARAMIS trial.
Source: medscape.com
Mathieu Kerneis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mathieu Kerneis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mathieu Kerneis Today - Breaking & Trending Today
'Our Goal Is Not to Blame': What We Heard This Week
Quotable quotes heard by <em>MedPage Today</em>'s reporters
Source: medpagetoday.com
ARAMIS trial finds no benefit of anakinra in acute myocarditis
The largest randomized controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking research presented in a Hot Line session today at ESC Congress 2023.
Source: news-medical.net
Immune Suppressant Stumbles for Acute Myocarditis in Early Data
Phase II trial might not end the story for anti-inflammatory approach, though
Source: medpagetoday.com